Issuer disclosure record

$ARQT

Company name unavailable

Transactions involving this ticker in readable 2022 House reports. This page describes disclosure activity, not the issuer’s performance and not a recommendation to trade.

Purchases

Sales

Filers

Reports

Transaction history

Who disclosed trading $ARQT?

Open in trade feed →

purchaseRep. Josh GottheimerNJ-05

$ARQTArcutis Biotherapeutics, Inc. - Common stock (ARQT)

Rep. Josh Gottheimer's filing reports that a joint account purchased · $1,001 – $15,000

View transaction source status →

Traded Jun 15, 2022Notified Jul 8, 2022Filed Jul 22, 202237 days to file

Owner: JointOriginal filing ↗